Efficacy and Safety of Canakinumab in Patients with Active Systemic Juvenile Idiopathic Arthritis and Fever: Results From Two Pivotal Phase 3 Trials.

Hermine I. Brunner; Nicolino Ruperto; Pierre Quartier; Tamas Constantin; Nico Wulffraat; Gerd Horneff; Riva Brik; Liza McCann; Huri Ozdogan; Lidia Rutkowska-Sak; Rayfel Schneider; Yackov Berkun; Inmaculada Calvo; Muferet Erguven; Laurence Goffin; Michael Hofer; Tilmann Kallinich; Karine Lheritier; Ken Abrams; Andrea Stancati; D. J. Lovell; Alberto Martini

Efficacy and Safety of Canakinumab in Patients with Active Systemic Juvenile Idiopathic Arthritis and Fever: Results From Two Pivotal Phase 3 Trials.

Hermine I. Brunner, Nicolino Ruperto, Pierre Quartier, Tamas Constantin, Nico Wulffraat, Gerd Horneff, Riva Brik, Liza McCann, Huri Ozdogan, Lidia Rutkowska-Sak, Rayfel Schneider, Yackov Berkun, Inmaculada Calvo, Muferet Erguven, Laurence Goffin, Michael Hofer, Tilmann Kallinich, Karine Lheritier, Ken Abrams, Andrea StancatiD. J. Lovell, Alberto Martini

Infection & Immunity

Research output: Contribution to journal › Meeting Abstract › Academic

Original language	English
Pages (from-to)	S326-S327
Journal	Arthritis and Rheumatism
Volume	64
Issue number	10
Publication status	Published - Oct 2012

Cite this

Brunner, H. I., Ruperto, N., Quartier, P., Constantin, T., Wulffraat, N., Horneff, G., Brik, R., McCann, L., Ozdogan, H., Rutkowska-Sak, L., Schneider, R., Berkun, Y., Calvo, I., Erguven, M., Goffin, L., Hofer, M., Kallinich, T., Lheritier, K., Abrams, K., ... Martini, A. (2012). Efficacy and Safety of Canakinumab in Patients with Active Systemic Juvenile Idiopathic Arthritis and Fever: Results From Two Pivotal Phase 3 Trials. Arthritis and Rheumatism, 64(10), S326-S327.

@article{8a053c36e63b40609d33090c2c38f39f,

title = "Efficacy and Safety of Canakinumab in Patients with Active Systemic Juvenile Idiopathic Arthritis and Fever: Results From Two Pivotal Phase 3 Trials.",

author = "Brunner, {Hermine I.} and Nicolino Ruperto and Pierre Quartier and Tamas Constantin and Nico Wulffraat and Gerd Horneff and Riva Brik and Liza McCann and Huri Ozdogan and Lidia Rutkowska-Sak and Rayfel Schneider and Yackov Berkun and Inmaculada Calvo and Muferet Erguven and Laurence Goffin and Michael Hofer and Tilmann Kallinich and Karine Lheritier and Ken Abrams and Andrea Stancati and Lovell, {D. J.} and Alberto Martini",

year = "2012",

month = oct,

language = "English",

volume = "64",

pages = "S326--S327",

journal = "Arthritis and Rheumatism",

issn = "0004-3591",

publisher = "John Wiley & Sons Inc.",

number = "10",

}

Brunner, HI, Ruperto, N, Quartier, P, Constantin, T, Wulffraat, N, Horneff, G, Brik, R, McCann, L, Ozdogan, H, Rutkowska-Sak, L, Schneider, R, Berkun, Y, Calvo, I, Erguven, M, Goffin, L, Hofer, M, Kallinich, T, Lheritier, K, Abrams, K, Stancati, A, Lovell, DJ & Martini, A 2012, 'Efficacy and Safety of Canakinumab in Patients with Active Systemic Juvenile Idiopathic Arthritis and Fever: Results From Two Pivotal Phase 3 Trials.', Arthritis and Rheumatism, vol. 64, no. 10, pp. S326-S327.

TY - JOUR

T1 - Efficacy and Safety of Canakinumab in Patients with Active Systemic Juvenile Idiopathic Arthritis and Fever: Results From Two Pivotal Phase 3 Trials.

AU - Brunner, Hermine I.

AU - Ruperto, Nicolino

AU - Quartier, Pierre

AU - Constantin, Tamas

AU - Wulffraat, Nico

AU - Horneff, Gerd

AU - Brik, Riva

AU - McCann, Liza

AU - Ozdogan, Huri

AU - Rutkowska-Sak, Lidia

AU - Schneider, Rayfel

AU - Berkun, Yackov

AU - Calvo, Inmaculada

AU - Erguven, Muferet

AU - Goffin, Laurence

AU - Hofer, Michael

AU - Kallinich, Tilmann

AU - Lheritier, Karine

AU - Abrams, Ken

AU - Stancati, Andrea

AU - Lovell, D. J.

AU - Martini, Alberto

PY - 2012/10

Y1 - 2012/10

M3 - Meeting Abstract

SN - 0004-3591

VL - 64

SP - S326-S327

JO - Arthritis and Rheumatism

JF - Arthritis and Rheumatism

IS - 10

ER -